Prevention and health services delivery.
Goldstein
Larry B
LB
Duke Center for Cerebrovascular Disease, Stroke Policy Program, Duke University and Durham VA Medical Center, Durham, North Carolina, USA. golds004@mc.duke.edu
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000975:Antioxidants / Q000008:administration & dosage; D019587:Dietary Supplements; D015914:Estrogen Replacement Therapy; D005247:Feeding Behavior; D005638:Fruit; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D009749:Nutrition Surveys; D011188:Potassium / Q000097:blood; D011322:Primary Prevention; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D012306:Risk; D012307:Risk Factors; D020521:Stroke / Q000453:epidemiology / Q000517:prevention & control* / Q000628:therapy*; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology; D014675:Vegetables
D000806:Angiotensin-Converting Enzyme Inhibitors; D000975:Antioxidants; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011188:Potassium